Australian M&A and equity raisings
1,881 deals since January 2025, each with its advisers and sources · as at 8 Nov 2026 · Venture rounds
116 deals · A$3.4bndisclosed · Health care · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value A$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Dec 2024 | Animalcare Group | – | – | Placement | Announced | 39.0 | Biotech and pharmaceuticals | Squire Patton Boggs (issuer) |
| Jan 2025 | Nova Eye Medical | – | – | Placement | Completed | 6.6 | Medical devices and technology | Taylor Collison (lead manager) |
| Feb 2025 | Micro-X | – | – | Entitlement offer | Completed | 6.4 | Medical devices and technology | Morgans (lead manager)Hawkesbury Partners (lead manager) |
| Feb 2025 | PYC Therapeutics | – | – | Entitlement offer | Completed | 146.0 | Biotech and pharmaceuticals | Tenzing Partners (issuer)E&P Capital (lead manager)Barrenjoey (lead manager) |
| Feb 2025 | 4DMedical | – | – | Placement | Completed | 13.9 | Medical devices and technology | Bell Potter (lead manager) |
| Feb 2025 | Ryman Healthcare | – | – | Entitlement offer | Announced | – | Hospitals, clinics and aged care | Jarden (lead manager) |
| Feb 2025 | Arovella Therapeutics | – | – | Placement | Announced | 15.0 | Biotech and pharmaceuticals | Ord Minnett (lead manager)Taylor Collison (lead manager) |
| Mar 2025 | Imricor Medical Systems | – | – | Placement | Completed | 70.0 | Medical devices and technology | Morgans (lead manager) |
| Mar 2025 | Bioxyne | – | – | Placement | Completed | 3.0 | Biotech and pharmaceuticals | Alpine Capital (lead manager) |
| Mar 2025 | The Hydration Pharmaceuticals Company | – | – | Placement | Completed | 0.7 | Biotech and pharmaceuticals | Evolution Capital (lead manager) |
| Mar 2025 | The Hydration Pharmaceuticals Company | – | – | Entitlement offer | Completed | 0.6 | Biotech and pharmaceuticals | Evolution Capital (lead manager) |
| Apr 2025 | Botanix Pharmaceuticals | – | – | Placement | Completed | 40.0 | Biotech and pharmaceuticals | Euroz Hartleys (lead manager)E&P Capital (lead manager) |
| Apr 2025 | NeuroScientific Biopharmaceuticals | – | – | Placement | Announced | 3.5 | Biotech and pharmaceuticals | Westar Capital (lead manager) |
| May 2025 | EBR Systems | – | – | Placement | Completed | 62.0 | Medical devices and technology | Johnson Winter Slattery (issuer) |
| May 2025 | AdAlta | – | – | Entitlement offer | Completed | 1.1 | Biotech and pharmaceuticals | Mahe Capital (lead manager) |
| May 2025 | BlinkLab | – | – | Placement | Completed | 7.7 | Medical devices and technology | Westar Capital (lead manager)Alpine Capital (lead manager) |
| May 2025 | Enlitic | – | – | Placement | Completed | 10.0 | Medical devices and technology | Taylor Collison (lead manager)MST Financial (lead manager) |
| May 2025 | Echo IQ | – | – | Placement | Completed | 17.3 | Medical devices and technology | Ord Minnett (lead manager) |
| May 2025 | OncoSil Medical | – | – | Placement | Completed | 8.7 | Medical devices and technology | Bell Potter (lead manager) |
| May 2025 | Pacific Edge | – | – | Placement | Completed | – | Medical devices and technology | Cameron Partners (issuer)Harmos Horton Lusk (issuer)The Project NZ (issuer) |
| May 2025 | TruScreen Group | – | – | Share purchase plan | Completed | – | Medical devices and technology | Russell McVeagh (issuer) |
| May 2025 | Cardiex | – | – | Entitlement offer | Completed | 6.5 | Medical devices and technology | Blackpeak Capital (lead manager)Stralis Capital Partners (lead manager)Taylor Collison (lead manager) |
| Jun 2025 | Recce Pharmaceuticals | – | – | Entitlement offer | Completed | 15.8 | Biotech and pharmaceuticals | Ord Minnett (lead manager)Spark Plus (lead manager) |
| Jun 2025 | Patrys | – | – | Placement | Completed | 0.4 | Biotech and pharmaceuticals | RM Corporate Finance (lead manager) |
| Jun 2025 | Invion | – | – | Entitlement offer | Completed | – | Biotech and pharmaceuticals | Blue Ocean Equities (lead manager) |
| Jun 2025 | TALi Digital | – | – | Placement | Completed | 1.5 | Medical devices and technology | Sequoia Corporate Finance (lead manager) |
| Jun 2025 | Singular Health Group | – | – | Placement | Completed | 8.0 | Medical devices and technology | Wallabi Group (lead manager) |
| Jun 2025 | Adherium | – | – | Entitlement offer | Completed | 4.0 | Medical devices and technology | PAC Partners (lead manager)Stralis Capital Partners (lead manager) |
| Jun 2025 | Tetratherix | – | – | IPO | Listed | 25.0 | Medical devices and technology | Nexia Australia (issuer)Barrenjoey (lead manager)Morgans (lead manager) |
| Jul 2025 | Prescient Therapeutics | – | – | Share purchase plan | Completed | – | Biotech and pharmaceuticals | Reach Markets (lead manager) |
| Jul 2025 | Vitasora Health | – | – | Placement | Completed | 11.0 | Medical devices and technology | Bell Potter (lead manager)MST Financial (lead manager) |
| Jul 2025 | Imugene | – | – | Placement | Completed | 22.5 | Biotech and pharmaceuticals | Bell Potter (lead manager)E&P Capital (lead manager) |
| Jul 2025 | Atomo Diagnostics | – | – | Placement | Completed | 0.4 | Medical devices and technology | Bay Financial (lead manager)GBA Capital (lead manager) |
| Jul 2025 | Amplia Therapeutics | – | – | Placement | Completed | 27.5 | Biotech and pharmaceuticals | Becketts Lawyers (issuer)Bell Potter (lead manager)Evolution Capital (lead manager) |
| Jul 2025 | Clarity Pharmaceuticals | – | – | Placement | Completed | 203.0 | Biotech and pharmaceuticals | Lander & Rogers (issuer)Bell Potter (lead manager) |
| Jul 2025 | PainChek | – | – | Placement | Completed | 7.5 | Medical devices and technology | Canaccord Genuity (lead manager) |
| Jul 2025 | Advanced Health Intelligence | – | – | Placement | Announced | 5.5 | Medical devices and technology | Oakley Capital Partners (lead manager) |
| Aug 2025 | Nyrada | – | – | Placement | Completed | 8.3 | Biotech and pharmaceuticals | Canary Capital (lead manager) |
| Aug 2025 | AVITA Medical | – | – | Placement | Completed | 24.0 | Medical devices and technology | MST Financial (lead manager) |
| Aug 2025 | dorsaVi | – | – | Placement | Completed | 5.0 | Medical devices and technology | Sixty Two Capital (lead manager)Evolution Capital (lead manager) |
| Aug 2025 | Rhythm Biosciences | – | – | Placement | Completed | 3.7 | Medical devices and technology | CPS Capital Group (lead manager) |
| Aug 2025 | Optiscan Imaging | – | – | Entitlement offer | Completed | 17.8 | Medical devices and technology | Steinepreis Paganin (issuer)Canaccord Genuity (issuer) |
| Sep 2025 | Artrya | – | – | Placement | Completed | 75.0 | Medical devices and technology | Petra Capital (lead manager) |
| Sep 2025 | AGH | – | – | Placement | Completed | 2.6 | Biotech and pharmaceuticals | Taurus Capital (lead manager) |
| Sep 2025 | EMVision Medical Devices | – | – | Placement | Completed | 12.0 | Medical devices and technology | Barrenjoey (lead manager)Bell Potter (lead manager) |
| Sep 2025 | CurveBeam AI | – | – | Placement | Completed | 6.5 | Medical devices and technology | Euroz Hartleys (lead manager)Spark Plus (lead manager) |
| Oct 2025 | EVE Health Group | – | – | Placement | Completed | 1.1 | Biotech and pharmaceuticals | Spark Plus (lead manager) |
| Oct 2025 | Nexsen | – | – | IPO | Listed | 6.0 | Medical devices and technology | Reign Advisory (issuer)Steinepreis Paganin (issuer)Moore Australia (issuer)Frost & Sullivan (issuer)Patenteur (issuer)Alpine Capital (lead manager) |
| Oct 2025 | INOVIQ | – | – | Placement | Completed | 9.5 | Biotech and pharmaceuticals | MinterEllison (issuer)PAC Partners (lead manager)Arlington Group (lead manager) |
| Oct 2025 | Biotron | – | – | Placement | Completed | 2.5 | Biotech and pharmaceuticals | Peak Asset Management (lead manager) |
Deals come from ASX announcements, scheme booklets, prospectuses, the advisers' own deal announcements and the press. How the data is built